So rare we need to hunt for them: Reframing the ethical debate on incidental findings

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Schuol, Sebastian ^a   Schickhardt, Christoph ^a   Wiemann, Stefan ^b   Bartram, Claus R ^a   Tanner, Klaus ^c   Eils, Roland ^b   Meder, Benjamin ^a   Richter, Daniela ^b   Glimm, Hanno ^b   von Kalle, Christof ^b   Winkler, Eva C ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN P53;

ARTICLE; BIOETHICS; CFTR GENE; GENE; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HUMAN; INCIDENTAL FINDING; MEDICAL RESEARCH; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RESEARCH ETHICS; TP53 GENE;

EID: 84939146777     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0198-3     Document Type: Article

References (34)

1. Online Mendelian Inheritance in Man. http://www.omim.org .
2. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36:219-48. doi: 10.1111/j.1748-720X.2008.00266.x .
3. Christenhusz GM, Devriendt K, Dierickx K. To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts. Eur J Hum Genet. 2013;21:248-55. doi: 10.1038/ejhg.2012.130 .
4. Zawati MH, Knoppers BM. International normative perspectives on the return of individual research results and incidental findings in genomic biobanks. Genet Med. 2012;14:484-9.
5. EURAT - Ethical and Legal Aspects of Whole Genome Sequencing. http://www.uni-heidelberg.de/totalsequenzierung/english.html .
6. EURAT-Group. Cornerstones for an ethically and legally informed practice of Whole Genome Sequencing. Heidelberg: Marsilius-Kolleg der Universität Heidelberg; 2013.
7. Bruno DL, Stark Z, Amor DJ, Burgess T, Butler K, Corrie S, et al. Extending the scope of diagnostic chromosome analysis: detection of single gene defects using high-resolution SNP microarrays. Hum Mutat. 2011;32:1500-6. doi: 10.1002/humu.21581 .
8. Kuan LC, Su MT, Kuo PL, Kuo TC. Direct duplication of the Y chromosome with normal phenotype - incidental finding in two cases. Andrologia. 2013;45:140-4. doi: 10.1016/j.pec.2012.09.01010.1111/j.1439-0272.2012.01320.x .
9. Lewis A, James P. An incidental finding of a large genomic deletion of BRCA1 on a molecular karyotype for a 5 year old child. Hered Cancer Clin Pract. 2012;10:A73. doi: 10.1186/1897-4287-10-S2-A73 .
10. Rostasy K, Fauth C, Gautsch K, Laimer I, Krabichler B, Wimmer K, et al. Modification of risk for cancer as a coincidental finding in DNA array investigation. Clin Genet. 2013;83:284-7. doi: 10.1111/j.1399-0004.2012.01881.x .
11. de Ligt J, Willemsen MH, van Bon BWM, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367:1921-9. doi: 10.1056/NEJMoa1206524 .
12. Williams JK, Daack-Hirsch S, Driessnack M, Downing N, Shinkunas L, Brandt D, et al. Researcher and institutional review board chair perspectives on incidental findings in genomic research. Genet Test Mol Biomarkers. 2012;16:508-13. doi: 10.1089/gtmb.2011.0248 .
13. Downing NR, Williams JK, Daack-Hirsch S, Driessnack M, Simon CM. Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting. Patient Educ Couns. 2013;90:133-8. doi: 10.1038/gim.2013.7310.1016/j.pec.2012.09.010 .
14. Klitzman R, Appelbaum PS, Fyer A, Martinez J, Buquez B, Wynn J, et al. Researchers' views on return of incidental genomic research results: qualitative and quantitative findings. Genet Med. 2013;15:888-95. doi: 10.1038/gim.2013.14010.1038/gim.2013.87 .
15. Klitzman R, Buquez B, Appelbaum PS, Fyer A, Chung WK. Processes and factors involved in decisions regarding return of incidental genomic findings in research. Genet Med. 2014;16:311-7. doi: 10.1038/gim.2014.2910.1038/gim.2013.140 .
16. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565-74. doi: 10.1038/gim.2013.8710.1038/gim.2013.73 .
17. Jurgens J, Ling H, Hetrick K, Pugh E, Schiettecatte F, Doheny K. Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics. Genet Med. 2015. doi: 10.1038/gim.2014.196 .
18. Lawrence L, Sincan M, Markello T, Adams DR, Gill F, Godfrey R, et al. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet Med. 2014;16:741-50. doi: 10.1038/gim.2014.29 .
19. Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH, et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015;25:305-15. doi: 10.1101/gr.183483.114 .
20. Furtado CD, Aguirre DA, Sirlin CB, Dang D, Stamato SK, Lee P, et al. Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology. 2005;237:385-94. doi: 10.1148/radiol.2372041741 .
21. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med. 2013;369:1502-11. doi: 10.1056/NEJMoa1306555 .
22. Collingridge D. The social control of technology. London: Pinter; 1980.
23. Liebert W, Schmidt J. Collingridge's dilemma and technoscience. Poiesis Prax. 2010;7:55-71. doi: 10.1007/s10202-010-0078-2 .
24. Christenhusz GM, Devriendt K, Vermeesch J, Dierickx K. Why genomics shouldn't get too personal: in favor of filters. Am J Med Genet A. 2012;158A:2641-2. doi: 10.1002/ajmg.a.35547 .
25. EuroGentest Guidelines for Diagnostic Next Generation Sequencing. http://www.eurogentest.org/fileadmin/templates/eugt/pdf/NGS_Guidelines/EuroGentest_NGS_guidelines_2014_-_final_draft_02-12-2014_v2.pdf .
26. Miller FG, Mello MM, Joffe S. Incidental findings in human subjects research: what do investigators owe research participants? J Law Med Ethics. 2008;36:271-11. doi: 10.1111/j.1748-720X.2008.00269.x .
27. Gliwa C, Berkman BE. Do researchers have an obligation to actively look for genetic incidental findings? Am J Bioethics. 2013;13:32-42. doi: 10.1080/15265161.2012.754062 .
28. Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen - The Clinical Genome Resource. N Engl J Med. 2015;372:2235-42. doi: 10.1056/NEJMsr1406261 .
29. Xue Y, Chen Y, Ayub Q, Huang N, Ball Edward V, Mort M, et al. Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet. 2012;91:1022-32. doi: 10.1016/j.ajhg.2012.10.015 .
30. Wright C, Burton H, Hall A, Moorthie S, Pokorska-Bocci A, Sagoo G, et al. Next steps in the sequence: the implications of whole genome sequencing for health in the UK. Cambridge: PHG Foundation; 2011.
31. Burke W, Matheny Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, et al. Recommendations for returning genomic incidental findings? We need to talk! Genet Med. 2013;15:854-9. doi: 10.1038/gim.2013.113 .
32. Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow LM, et al. Managing incidental findings and research results in genomic research involving biobanks & archived datasets. Genet Med. 2012;14:361-84. doi: 10.1038/gim.2012.23 .
33. Berg JSKM, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med. 2011;13:499-504. doi: 10.1097/GIM.0b013e318220aaba .
34. Shkedi-Rafid S, Dheensa S, Crawford G, Fenwick A, Lucassen A. Defining and managing incidental findings in genetic and genomic practice. J Med Genet. 2014;51:715-23. doi: 10.1136/jmedgenet-2014-102435 .